Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ryan MacDonald
NDM
Ryan MacDonald
Wall Street Analyst
★★★☆☆
#943
on 13Foresight · ranked by our own returns
57%
Success Rate
+9.6%
Average Return
26 of 46 calls profitable · -37691.3% vs benchmark
📈 Across the calls we could measure, roughly 57% of Ryan MacDonald's ratings turned a profit when each position was held for 1 year — averaging +9.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

85 Buy 31 Hold 0 Sell
Ryan's Stock Coverage 44 ratings · 2026-06-20
Company Date Position Consensus Price Target 1-Yr Return
MH
McGraw Hill, Inc.
Jun 11, 2026 BUY Strong Buy
+84.1% avg upside
12 analysts
$19.00
96.32% Upside
-18.3%
HNGE
Hinge Health, Inc. Class A
Jun 11, 2026 BUY Strong Buy
+7.2% avg upside
17 analysts
$76.00
9.56% Upside
+3.5%
VEEV
Veeva Systems
Jun 04, 2026 BUY Strong Buy
+54.2% avg upside
36 analysts
$270.00
76.06% Upside
-5.5%
ODD
ODDITY Tech Ltd. Class A
Jun 02, 2026 HOLD Sell
+26.5% avg upside
12 analysts
+32.8%
TEM
Tempus AI, Inc. Class A
Jun 01, 2026 BUY Strong Buy
+33.4% avg upside
19 analysts
$75.00
47.44% Upside
-4.2%
PHR
Phreesia
May 28, 2026 BUY Strong Buy
+82.1% avg upside
21 analysts
$14.00
49.20% Upside
·
DOCS
Doximity
May 14, 2026 BUY Buy
+61.4% avg upside
27 analysts
$27.00
32.06% Upside
+14.8%
TSE:DCBO
Docebo
May 13, 2026 BUY Strong Buy
+94.2% avg upside
15 analysts
$43.39
77.48% Upside
·
DCGO
DocGo
May 12, 2026 BUY Buy
+420.4% avg upside
7 analysts
$3.00
472.95% Upside
-1.7%
HIMS
Hims & Hers Health
May 12, 2026 BUY Buy
-27.8% avg upside
22 analysts
$35.00
1.36% Downside
+8.6%
NRDY
Nerdy
May 08, 2026 BUY Buy
+183.5% avg upside
13 analysts
$2.00
133.84% Upside
-3.5%
OMDA
Omada Health, Inc.
May 08, 2026 BUY Strong Buy
+32.0% avg upside
11 analysts
$28.00
58.83% Upside
+17.9%
DH
Definitive Healthcare Corp
May 08, 2026 HOLD Buy
+660.4% avg upside
19 analysts
-11.1%
CHGG
Chegg
May 07, 2026 HOLD Hold
+2422.2% avg upside
23 analysts
-18.8%
AMWL
American Well
May 06, 2026 HOLD Hold
+64.6% avg upside
15 analysts
+5.0%
DUOL
Duolingo
May 05, 2026 BUY Buy
+20.8% avg upside
27 analysts
$145.00
15.53% Upside
+18.6%
TDOC
Teladoc
Apr 30, 2026 HOLD Buy
+257.6% avg upside
37 analysts
+17.0%
WAY
Waystar Holding Corp.
Apr 30, 2026 BUY Strong Buy
+105.7% avg upside
29 analysts
$33.00
78.75% Upside
-13.9%
COUR
Coursera
Apr 24, 2026 BUY Buy
+134.6% avg upside
23 analysts
$10.00
86.96% Upside
+0.0%
LPSN
Liveperson
Mar 13, 2026 HOLD Buy
+1047.0% avg upside
26 analysts
-20.3%
TALK
Talkspace
Mar 09, 2026 HOLD Buy
-13.1% avg upside
12 analysts
+1.6%
YEXT
Yext
Dec 09, 2025 BUY Buy
+294.7% avg upside
11 analysts
$10.00
163.24% Upside
-58.9%
ZETA
Zeta Global Holdings Corp
May 02, 2025 BUY Strong Buy
+34.9% avg upside
22 analysts
$25.00
32.36% Upside
+36.0%
BNED
Barnes & Noble Education
May 24, 2024 HOLD Hold
-25.7% avg upside
7 analysts
-81.8%
PAYC
Paycom
Nov 01, 2023 HOLD Buy
+65.2% avg upside
32 analysts
+41.0%
THC
Tenet Healthcare
Jun 20, 2023 BUY Strong Buy
+25.9% avg upside
26 analysts
$92.00
46.61% Downside
+72.5%
CNC
Centene
Jun 20, 2023 BUY Buy
+8.6% avg upside
28 analysts
$83.00
36.09% Upside
+2.4%
ASUR
Asure
Feb 28, 2023 BUY Strong Buy
+59.8% avg upside
17 analysts
$20.00
141.89% Upside
-32.8%
HUBS
HubSpot
Nov 03, 2022 BUY Strong Buy
+85.2% avg upside
45 analysts
$500.00
183.96% Upside
+51.8%
EGAN
eGain
Jul 07, 2021 HOLD Buy
+25.3% avg upside
13 analysts
-6.0%
BLKB
Blackbaud
Jul 07, 2021 HOLD Buy
+156.3% avg upside
13 analysts
-22.5%
ORCL
Oracle
Jun 22, 2017 HOLD Strong Buy
+19.0% avg upside
70 analysts
$46.00
74.98% Downside
-10.9%
ADBE
Adobe
Jun 21, 2017 BUY Buy
+61.3% avg upside
52 analysts
$165.00
15.53% Downside
+72.5%
WDAY
Workday
Feb 28, 2017 HOLD Strong Buy
+71.4% avg upside
53 analysts
$86.00
26.46% Downside
+52.7%
CRM
Salesforce
Feb 27, 2017 BUY Strong Buy
+61.4% avg upside
70 analysts
$101.00
33.47% Downside
+42.8%
MSFT
Microsoft
Jan 27, 2017 BUY Strong Buy
+11.4% avg upside
90 analysts
$75.00
80.32% Downside
+46.2%
NOW
ServiceNow
Jan 26, 2017 BUY Strong Buy
+125.9% avg upside
55 analysts
$107.00
12.61% Upside
+67.3%
CHKP
Check Point
Sep 13, 2016 HOLD Buy
+21.0% avg upside
47 analysts
$80.00
34.57% Downside
+47.7%
QLYS
Qualys
Sep 13, 2016 BUY Hold
-8.2% avg upside
29 analysts
$43.00
61.43% Downside
+43.0%
GEN
Gen Digital
Sep 13, 2016 BUY Buy
+17.5% avg upside
41 analysts
$30.00
24.02% Upside
+35.4%
PANW
Palo Alto Networks
Sep 13, 2016 BUY Strong Buy
-7.0% avg upside
73 analysts
$190.00
34.00% Downside
-2.0%
PGEN
Precigen
Jul 07, 2016 BUY Buy
+404.8% avg upside
11 analysts
$50.00
937.34% Upside
·
TBCH
Turtle Beach
Dec 26, 2014 HOLD Strong Buy
+21.7% avg upside
12 analysts
$3.00
78.21% Downside
-27.4%
QMCO
Quantum
Mar 06, 2014 BUY Buy
-51.6% avg upside
7 analysts
$1.50
90.37% Downside
+41.9%
🔒 39 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Ryan MacDonald — Frequently Asked Questions
How accurate are Ryan MacDonald's stock ratings?
Based on the calls 13Foresight could measure, about 57% of Ryan's ratings were profitable over a one-year hold, with an average return of +9.6% per rating, or -0.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ryan ranked on 13Foresight?
Ryan MacDonald is currently ranked #943 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ryan cover?
Ryan most recently has ratings on MH, HNGE, VEEV, ODD, TEM, PHR, DOCS, TSE:DCBO, DCGO, HIMS, NRDY, OMDA and 32 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.